Subjecting the new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures *
European Parliament legislative resolution of 14 February 2017 on the draft Council implementing decision on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures (12356/2016 – C8-0405/2016 – 2016/0262(NLE))
(Consultation)
The European Parliament,
– having regard to the Council draft (12356/2016),
– having regard to Article 39(1) of the Treaty on European Union, as amended by the Treaty of Amsterdam, and Article 9 of Protocol No 36 on transitional provisions, pursuant to which the Council consulted Parliament (C8‑0405/2016),
– having regard to Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk‑assessment and control of new psychoactive substances(1), and in particular Article 8(3) thereof,
– having regard to Rule 78c of its Rules of Procedure,
– having regard to the report of the Committee on Civil Liberties, Justice and Home Affairs (A8-0024/2017),
1. Approves the Council draft;
2. Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament;
3. Asks the Council to consult Parliament again if it intends to substantially amend the text approved by Parliament;
4. Instructs its President to forward its position to the Council and the Commission.